Study at a glance
How can vitamin D processing go wrong?
This page summarises evidence about disorders of vitamin D processing. It combines human genetic disorders, animal experiments and laboratory cell studies rather than reporting one clinical trial. The central distinction is between failing to make enough active vitamin D, failing to remove vitamin D compounds normally, and making too much active vitamin D outside the kidneys.
What happens when vitamin D activation or removal fails?
Enzymes are proteins that help chemical reactions occur. CYP27B1 helps make calcitriol, the active vitamin D hormone. Severe loss of this enzyme can cause rickets, in which growing bones do not harden properly, even when an earlier form of vitamin D is available. CYP24A1 helps process vitamin D compounds for removal. Its failure can cause high calcium in blood or urine and kidney complications. The severity varies between people.
How do hormones and disease affect the active vitamin D supply?
Parathyroid hormone usually favours production of active vitamin D. FGF23 and active vitamin D itself tend to reduce production and promote further processing. Kidney disease can reduce activation without an inherited enzyme defect. In certain diseases, including sarcoidosis and tuberculosis, immune cells outside the kidneys can produce enough active vitamin D to contribute to high blood calcium.
What do these vitamin D disorders not show about other people?
Some processes remain uncertain. These include conflicting effects of the hormone calcitonin and incomplete explanations of how the body detects calcium and phosphate levels. Results from animal or cell experiments do not directly show how large the effects are in people. The review does not show that every difference in a gene causes severe disease, that enzyme faults commonly explain vague symptoms, or that ordinary activity outside the kidneys supplies most active vitamin D in the blood.
Read the full article below ↓Young and colleagues review what happens when vitamin D activation and inactivation move too far in either direction. The clearest disease mechanisms are deliberately different: CYP27B1 loss prevents adequate calcitriol formation, CYP24A1 loss prevents normal vitamin D metabolite inactivation, and dysregulated extra-renal CYP27B1 can produce excessive calcitriol in granulomatous disease. The review also explains how those disorders sit within normal renal feedback involving PTH, calcitriol, FGF23, calcitonin, calcium and phosphate.
What is the normal physiological setting?
The kidney is the principal regulated source of circulating calcitriol. In proximal tubular cells, 25(OH)D is delivered to mitochondrial CYP27B1 for 1α-hydroxylation, while CYP24A1 promotes further metabolism of 25(OH)D and calcitriol.
The two enzymes are regulated reciprocally within the broader Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1) system. PTH generally favours calcitriol availability; calcitriol feeds back to suppress CYP27B1 and induce CYP24A1; and FGF23 shifts the balance toward lower active-hormone production and greater catabolic pressure.
How does the review build the disease mechanisms?
This is a narrative review rather than one clinical trial. It links human genetic disorders with animal physiology, promoter experiments and cell-signalling studies. That mixture is useful because different evidence types answer different questions: human mutations show that loss of a particular enzyme can cause disease, animal models quantify regulatory responses that cannot easily be manipulated in people, and cellular experiments help identify signalling pathways. Numerical effects therefore retain the boundaries of the model in which they were measured.
What happens when CYP27B1 is lost?
Pathogenic CYP27B1 loss-of-function causes vitamin-D-dependent rickets type 1A. The biochemical defect lies after 25(OH)D formation, so precursor can be present while calcitriol remains inadequate.
The phenotype includes hypocalcaemia, hypophosphataemia, secondary hyperparathyroidism and rickets. Calcitriol treatment can bypass the missing enzyme step, which is strong evidence that the disease is an activation defect rather than simply a shortage of vitamin D precursor. Chronic kidney disease can also reduce calcitriol production, but through loss of functioning renal tissue and altered endocrine regulation rather than a primary CYP27B1 mutation. The distinction matters because similar low-calcitriol physiology can arise from different upstream causes.
What happens when CYP24A1 is lost?
CYP24A1 loss creates the opposite problem. Vitamin D metabolites are not inactivated normally, increasing exposure and creating a tendency toward hypercalcaemia and hypercalciuria. Recognised phenotypes include idiopathic infantile hypercalcaemia and later nephrolithiasis or nephrocalcinosis.
Clinical severity varies, so a CYP24A1 variant should not automatically be equated with the most severe infantile presentation. The robust mechanistic point is impaired degradation, not one fixed disease severity.
How can extra-renal CYP27B1 cause hypercalcaemia?
Activated macrophages in granulomatous disease can express CYP27B1 and generate calcitriol outside the kidney. In conditions such as sarcoidosis and tuberculosis, this local enzyme capacity can become large enough to contribute to systemic hypercalcaemia.
This is excessive production rather than failed clearance. It also should not be projected onto ordinary extra-renal physiology, where CYP27B1 often supports local signalling without dominating circulating calcitriol.
What do PTH and FGF23 show about the enzyme balance?
PTH stimulates CYP27B1 and also weakens the catabolic side. The review reports an approximately fourfold reduction in CYP24A1 mRNA half-life in the presence of PTH. This allows one hormone to favour active vitamin D through both increased synthesis and reduced catabolic transcript persistence.
FGF23 works in the opposite direction. In FGF23-null mice, renal CYP27B1 promoter activity was about threefold higher, while renal Cyp24a1 mRNA was about 63% lower than in wild type. These results support reciprocal control of activation and catabolism.
Which parts of the regulatory model remain uncertain?
Calcitonin generally stimulates CYP27B1, but its effect on CYP24A1 differs between experimental systems. In calcitonin-receptor-transfected HEK-293 cells, PKA or PKC inhibition reduced the induced CYP24A1 response by about 60%, while animal studies described a different direction of effect. The discrepancy remains unresolved.
Low phosphate can increase calcitriol production by roughly threefold, but the sensing pathway is not fully mapped and can depend on pituitary influences in experimental models. Calcium can also suppress Cyp27b1 in controlled animal experiments, although the complete signalling route remains incomplete.
What should a reader take from the disease evidence?
CYP27B1 failure, CYP24A1 failure and pathological extra-renal activation are not interchangeable forms of “enzyme imbalance.” They are distinct mechanisms that alter the same mineral-homeostasis network from different directions.
The review supports these defined disorders and regulatory pathways. It does not show that clinically important CYP27B1/CYP24A1 dysfunction is a common explanation for nonspecific symptoms, and it does not imply that every genetic variant produces severe disease. The useful clinical lesson is mechanistic: before interpreting an abnormal vitamin D pattern, ask whether the dominant problem is impaired activation, impaired degradation, excessive extra-renal production or a broader renal/endocrine disturbance.
Primary source and further reading
Young K, Beggs MR, Grimbly C, Alexander RT. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule. Experimental Biology and Medicine (Maywood). 2022;247(13):1103 to 1111. PMID 35482362; PMCID PMC9335508; DOI 10.1177/15353702221091982.
Read the full Young et al. review. The Full Evidence Review develops the regulatory experiments and disease boundaries in greater depth.
Related reading
Characterization of vitamin D3 biotransformation by the cell lysate of Actinomyces hyovaginalis CCASU-A11-2
Therefore, the objective of this study was to shorten the bioconversion time by using cell-free lysate and studying different factors influencing bioconversion.
Original paper ↗Read more →Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial
This secondary analysis of the DASH trial aimed to determine the effect of dietary patterns on blood concentrations of calcitriol, parathyroid hormone (PTH), ionized calcium, and urinary excretion of calcium and phosphorus.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients
To date, data simultaneously evaluating these parameters and interwoven relations on renal outcomes are scarce.
Original paper ↗Read more →The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice
We found that 1,25-dihydroxyvitamin D levels in plasma were significantly lower in the high phosphate group than the low phosphate group for 1 and 2 month-old mice, but not 13 month-old mice.
Original paper ↗Read more →Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
This study examined changes in plasma and effluent levels of total calcium, phosphate, PTH, and FGF-23 in individuals undergoing TPE.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Pathophysiological consequences of altered enzyme activity: Full Study Summary
Explore how altered CYP27B1 and CYP24A1 activity can disrupt vitamin D activation and clearance and contribute to clinically important metabolic disorders.SLUG:altered-cyp27b1-cyp24a1-enzyme-activity-full-evidence-review.
Read more →Dietary phosphorus source reprograms the kidney-intestine axis to dictate calcium-phosphorus efficiency and egg production in aging hens
The decline in egg production in aging hens poses a significant challenge to sustainable poultry production.
Original paper ↗Read more →Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function
Plasma approaches metastability with respect to its calcium and phosphate content, with only minor perturbations in ionic activity needed to sustain crystal growth once nucleated.
Original paper ↗Read more →Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults without confounding cardiovascular disease.
Original paper ↗Read more →High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss
Phosphate overload contributes to mineral bone disorders that are associated with crystal nephropathies.
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Klotho in the kidney distal convolution regulates urinary Klotho excretion and kidney calcium reabsorption, but not phosphate homeostasis
Klotho acts as a coreceptor for the phosphaturic hormone fibroblast growth factor-23 (FGF-23) and exists in both a membrane-bound and a soluble form (sKlotho) found in blood and urine.
Original paper ↗Read more →Loss of 24-hydroxylated catabolism increases calcitriol and fibroblast growth factor 23 and alters calcium and phosphate metabolism in fetal mice
The null fetuses were hypercalcemic, modestly hypophosphatemic (compared to Cyp24a1+/− fetuses only), with 3.5-fold increased calcitriol, 4-fold increased fibroblast growth factor 23 (FGF23), and unchanged parathyroid hormone.
Original paper ↗Read more →Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)
This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants.
Original paper ↗Read more →The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis: clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD.
Original paper ↗Read more →Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates
Serum 25(OH)D3 and 1,25(OH) 2D3 concentrations were significantly lower in septic and SNS compared to healthy foals (P.
Original paper ↗Read more →Original sources
Read the full Young et al. review
Read the full Young et al.
Publication details
Read the full Young et al. review. The Full Evidence Review develops the regulatory experiments and disease boundaries in greater depth.